MGTA Annual Working Capital
$101.05 M
-$68.78 M-40.50%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual working capital is $101.05 million, with the most recent change of -$68.78 million (-40.50%) on December 31, 2022. During the last 3 years, it has fallen by -$34.67 million (-25.55%).MGTA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Working Capital
$74.60 M
-$2.85 M-3.69%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly working capital is $74.60 million, with the most recent change of -$2.85 million (-3.69%) on June 30, 2023. Over the past year, it has dropped by -$56.18 million (-42.96%).MGTA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | -43.0% |
| 3 y3 years | -25.6% | -56.0% |
| 5 y5 years | +109.0% | -55.7% |
MGTA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -40.5% | -62.5% |
Magenta Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $74.60 M(-3.7%) |
| Mar 2023 | - | $77.46 M(-23.3%) |
| Dec 2022 | $101.05 M(-40.5%) | $101.05 M(-15.2%) |
| Sept 2022 | - | $119.18 M(-8.9%) |
| June 2022 | - | $130.79 M(-10.5%) |
| Mar 2022 | - | $146.15 M(-13.9%) |
| Dec 2021 | $169.83 M(+21.2%) | $169.83 M(-8.9%) |
| Sept 2021 | - | $186.33 M(-6.4%) |
| June 2021 | - | $199.10 M(+58.2%) |
| Mar 2021 | - | $125.89 M(-10.1%) |
| Dec 2020 | $140.10 M | $140.10 M(-9.3%) |
| Sept 2020 | - | $154.40 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $169.51 M(+40.8%) |
| Mar 2020 | - | $120.43 M(-11.3%) |
| Dec 2019 | $135.73 M(+0.6%) | $135.73 M(-12.8%) |
| Sept 2019 | - | $155.60 M(-10.1%) |
| June 2019 | - | $173.07 M(+36.1%) |
| Mar 2019 | - | $127.16 M(-5.7%) |
| Dec 2018 | $134.90 M(+178.9%) | $134.90 M(-10.6%) |
| Sept 2018 | - | $150.94 M(-10.3%) |
| June 2018 | - | $168.32 M(+353.3%) |
| Mar 2018 | - | $37.13 M(-23.2%) |
| Dec 2017 | $48.36 M(+466.7%) | $48.36 M |
| Dec 2016 | $8.53 M | - |
FAQ
- What is Magenta Therapeutics annual working capital?
- What is the all time high annual working capital for Magenta Therapeutics?
- What is Magenta Therapeutics annual working capital year-on-year change?
- What is Magenta Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly working capital year-on-year change?
What is Magenta Therapeutics annual working capital?
The current annual working capital of MGTA is $101.05 M
What is the all time high annual working capital for Magenta Therapeutics?
Magenta Therapeutics all-time high annual working capital is $169.83 M
What is Magenta Therapeutics annual working capital year-on-year change?
Over the past year, MGTA annual working capital has changed by -$68.78 M (-40.50%)
What is Magenta Therapeutics quarterly working capital?
The current quarterly working capital of MGTA is $74.60 M
What is the all time high quarterly working capital for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly working capital is $199.10 M
What is Magenta Therapeutics quarterly working capital year-on-year change?
Over the past year, MGTA quarterly working capital has changed by -$56.18 M (-42.96%)